SOLV
Solventum Corp
Company overview
- Market capitalization
- $15.24B
- Employees
- 20,584
- Latest publication
- 2026-09-29
About Solventum Corp
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,209,000,000USD | 2,007,000,000USD | 1,998,000,000USD | 2,096,000,000USD | 2,161,000,000USD | 2,070,000,000USD | 2,075,000,000USD | 2,082,000,000USD |
| Cost Of Revenue | 922,000,000USD | 910,000,000USD | 1,013,000,000USD | 919,000,000USD | 986,000,000USD | 956,000,000USD | 956,000,000USD | 917,000,000USD |
| Gross Profit | 1,286,000,000USD | 1,097,000,000USD | 985,000,000USD | 1,177,000,000USD | 1,175,000,000USD | 1,114,000,000USD | 1,119,000,000USD | 1,165,000,000USD |
| Research Development | 178,000,000USD | 189,000,000USD | 176,000,000USD | 183,000,000USD | 189,000,000USD | 193,000,000USD | 199,000,000USD | 189,000,000USD |
| Selling General Administrative | 927,000,000USD | 827,000,000USD | 759,000,000USD | 780,000,000USD | 772,000,000USD | 769,000,000USD | 784,000,000USD | 701,000,000USD |
| Total Operating Expenses | 1,105,000,000USD | 1,016,000,000USD | -693,000,000USD | 1,040,000,000USD | 961,000,000USD | 962,000,000USD | 983,000,000USD | 890,000,000USD |
| Operating Income | 181,000,000USD | 81,000,000USD | 1,678,000,000USD | 137,000,000USD | 214,000,000USD | 152,000,000USD | 136,000,000USD | 275,000,000USD |
| Total Other Income Expense Net | -73,000,000USD | -65,000,000USD | -1,620,000,000USD | 1,377,000,000USD | -111,000,000USD | -114,000,000USD | -123,000,000USD | -108,000,000USD |
| Income Before Tax | 108,000,000USD | 16,000,000USD | 58,000,000USD | 1,514,000,000USD | 103,000,000USD | 38,000,000USD | 13,000,000USD | 167,000,000USD |
| Income Tax Expense | 15,000,000USD | 3,000,000USD | -5,000,000USD | 248,000,000USD | 13,000,000USD | -99,000,000USD | -17,000,000USD | 45,000,000USD |
| Net Income | 92,000,000USD | 13,000,000USD | 63,000,000USD | 1,266,000,000USD | 90,000,000USD | 137,000,000USD | 31,000,000USD | 122,000,000USD |
| Interest Expense | — | 62,000,000USD | 51,000,000USD | 89,000,000USD | 103,000,000USD | 104,000,000USD | 107,000,000USD | 107,000,000USD |
| Net Interest Income | — | -62,000,000USD | -51,000,000USD | -89,000,000USD | -103,000,000USD | -104,000,000USD | -107,000,000USD | -107,000,000USD |
| Tax Provision | — | 3,000,000USD | -5,000,000USD | 248,000,000USD | 13,000,000USD | -99,000,000USD | -17,000,000USD | 45,000,000USD |
| Net Income From Continuing Ops | — | 13,000,000USD | 63,000,000USD | 1,266,000,000USD | 90,000,000USD | 137,000,000USD | 30,000,000USD | 122,000,000USD |
| Ebit | — | 78,000,000USD | 109,000,000USD | 1,603,000,000USD | 206,000,000USD | 142,000,000USD | 120,000,000USD | 274,000,000USD |
| Ebitda | — | 213,000,000USD | 489,000,000USD | 1,724,000,000USD | 328,000,000USD | 271,000,000USD | 270,000,000USD | 407,000,000USD |
| Depreciation And Amortization | — | 135,000,000USD | 380,000,000USD | 121,000,000USD | 122,000,000USD | 129,000,000USD | 150,000,000USD | 133,000,000USD |
| Reconciled Depreciation | — | 135,000,000USD | 117,000,000USD | 121,000,000USD | 122,000,000USD | 129,000,000USD | 150,000,000USD | 133,000,000USD |
| Unclassified Operating Expenses | — | — | -1,628,000,000USD | 77,000,000USD | — | — | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Revenue | 8,325,000,000USD | 8,254,000,000USD | 8,197,000,000USD | 8,130,000,000USD | 8,171,000,000USD | 7,281,000,000USD |
| Cost Of Revenue | 3,874,000,000USD | 3,661,000,000USD | 3,504,000,000USD | 3,435,000,000USD | 3,248,000,000USD | 2,966,000,000USD |
| Gross Profit | 4,451,000,000USD | 4,593,000,000USD | 4,693,000,000USD | 4,695,000,000USD | 4,923,000,000USD | 4,315,000,000USD |
| Research Development | 739,000,000USD | 775,000,000USD | 758,000,000USD | 767,000,000USD | 766,000,000USD | 719,000,000USD |
| Selling General Administrative | 3,080,000,000USD | 2,782,000,000USD | 2,321,000,000USD | 2,235,000,000USD | 2,278,000,000USD | 2,166,000,000USD |
| Unclassified Operating Expenses | -1,549,000,000USD | — | -78,000,000USD | — | — | — |
| Total Operating Expenses | 2,270,000,000USD | 3,557,000,000USD | 3,001,000,000USD | 3,002,000,000USD | 3,044,000,000USD | 2,885,000,000USD |
| Operating Income | 2,181,000,000USD | 1,036,000,000USD | 1,692,000,000USD | 1,693,000,000USD | 1,879,000,000USD | 1,430,000,000USD |
| Interest Expense | 347,000,000USD | 367,000,000USD | 0USD | 0USD | — | — |
| Net Interest Income | -347,000,000USD | -367,000,000USD | 0USD | 0USD | — | — |
| Income Before Tax | 1,713,000,000USD | 605,000,000USD | 1,667,000,000USD | 1,692,000,000USD | 1,882,000,000USD | 1,440,000,000USD |
| Income Tax Expense | 157,000,000USD | 127,000,000USD | 321,000,000USD | 349,000,000USD | 422,000,000USD | 302,000,000USD |
| Tax Provision | 157,000,000USD | 127,000,000USD | 218,000,000USD | 349,000,000USD | 422,000,000USD | 302,000,000USD |
| Net Income | 1,556,000,000USD | 479,000,000USD | 1,346,000,000USD | 1,343,000,000USD | 1,460,000,000USD | 1,138,000,000USD |
| Net Income From Continuing Ops | 1,556,000,000USD | 478,000,000USD | 692,000,000USD | 1,343,000,000USD | 1,460,000,000USD | 1,138,000,000USD |
| Ebit | 2,060,000,000USD | 972,000,000USD | 1,667,000,000USD | 1,692,000,000USD | 1,882,000,000USD | 1,430,000,000USD |
| Ebitda | 2,549,000,000USD | 1,527,000,000USD | 2,228,000,000USD | 2,270,000,000USD | 2,479,000,000USD | 2,029,000,000USD |
| Depreciation And Amortization | 489,000,000USD | 555,000,000USD | 561,000,000USD | 578,000,000USD | 597,000,000USD | 599,000,000USD |
| Reconciled Depreciation | 489,000,000USD | 555,000,000USD | 561,000,000USD | 578,000,000USD | 597,000,000USD | 599,000,000USD |
| Total Other Income Expense Net | -468,000,000USD | -431,000,000USD | -25,000,000USD | -1,000,000USD | 3,000,000USD | 10,000,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 14,243,000,000USD | 14,097,000,000USD | 14,294,000,000USD | 13,973,000,000USD | 15,074,000,000USD | 14,527,000,000USD | 14,457,000,000USD | 14,745,000,000USD |
| Cash And Equivalents | 403,000,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 3,741,000,000USD | 3,583,000,000USD | 3,859,000,000USD | 4,407,000,000USD | 3,208,000,000USD | 3,053,000,000USD | 3,249,000,000USD | 3,354,000,000USD |
| Other Current Assets | 865,000,000USD | 874,000,000USD | 881,000,000USD | 697,000,000USD | 499,000,000USD | 542,000,000USD | 293,000,000USD | 524,000,000USD |
| Other Non Current Assets | 904,000,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 9,443,000,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 3,663,000,000USD | 3,346,000,000USD | 3,136,000,000USD | 2,938,000,000USD | 2,620,000,000USD | 2,566,000,000USD | 2,703,000,000USD | 2,904,000,000USD |
| Other Current Liabilities | 1,528,000,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 486,000,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 4,800,000,000USD | 4,969,000,000USD | 5,049,000,000USD | 4,986,000,000USD | 3,645,000,000USD | 3,262,000,000USD | 2,959,000,000USD | 3,192,000,000USD |
| Total Equity Including Noncontrolling Interest | 4,800,000,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 0USD | 505,000,000USD | — | — | — | 100,000,000USD | 200,000,000USD | 300,000,000USD |
| Long Term Debt | 4,573,000,000USD | 4,575,000,000USD | 5,035,000,000USD | 5,137,000,000USD | 7,815,000,000USD | 7,813,000,000USD | 7,810,000,000USD | 7,809,000,000USD |
| Deferred Revenue | 596,000,000USD | — | — | — | — | — | — | — |
| Net Receivables | 1,310,000,000USD | 1,059,000,000USD | 1,034,000,000USD | 1,019,000,000USD | 1,255,000,000USD | 1,111,000,000USD | 1,229,000,000USD | 1,105,000,000USD |
| Inventory | 1,040,000,000USD | 1,089,000,000USD | 1,066,000,000USD | 1,049,000,000USD | 962,000,000USD | 866,000,000USD | 965,000,000USD | 953,000,000USD |
| Property Plant Equipment Net | 1,753,000,000USD | 1,543,000,000USD | 1,326,000,000USD | 1,336,000,000USD | 1,313,000,000USD | 1,198,000,000USD | 1,622,000,000USD | 1,599,000,000USD |
| Goodwill | 5,626,000,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 2,408,000,000USD | 2,497,000,000USD | 2,592,000,000USD | 2,223,000,000USD | 2,302,000,000USD | 2,365,000,000USD | 2,544,000,000USD | 2,651,000,000USD |
| Accounts Payable | 701,000,000USD | 699,000,000USD | 687,000,000USD | 669,000,000USD | 643,000,000USD | 604,000,000USD | 618,000,000USD | 560,000,000USD |
| Short Term Debt | 506,000,000USD | 505,000,000USD | — | — | — | 100,000,000USD | 200,000,000USD | 300,000,000USD |
| Common Stock | 2,000,000USD | 2,000,000USD | 2,000,000USD | 2,000,000USD | 2,000,000USD | 2,000,000USD | 2,000,000USD | 2,000,000USD |
| Retained Earnings | 1,902,000,000USD | 1,810,000,000USD | 1,797,000,000USD | 1,734,000,000USD | 468,000,000USD | 378,000,000USD | 242,000,000USD | 211,000,000USD |
| Accumulated Other Comprehensive Income | -669,000,000USD | -670,000,000USD | -625,000,000USD | -604,000,000USD | -631,000,000USD | -899,000,000USD | -1,056,000,000USD | -765,000,000USD |
| Total Liab | — | 9,128,000,000USD | 9,245,000,000USD | 8,987,000,000USD | 11,429,000,000USD | 11,265,000,000USD | 11,498,000,000USD | 11,553,000,000USD |
| Other Current Liab | — | 1,529,000,000USD | 1,828,000,000USD | 1,693,000,000USD | 1,303,000,000USD | 1,164,000,000USD | 1,191,000,000USD | 1,481,000,000USD |
| Capital Stock | — | 2,000,000USD | 2,000,000USD | 2,000,000USD | 2,000,000USD | 2,000,000USD | 2,000,000USD | 2,000,000USD |
| Good Will | — | 5,626,000,000USD | 5,704,000,000USD | 5,260,000,000USD | 5,274,000,000USD | 4,991,000,000USD | 6,377,000,000USD | 6,592,000,000USD |
| Cash | — | 561,000,000USD | 878,000,000USD | 1,642,000,000USD | 492,000,000USD | 534,000,000USD | 762,000,000USD | 772,000,000USD |
| Cash And Short Term Investments | — | 561,000,000USD | 878,000,000USD | 1,642,000,000USD | 492,000,000USD | 534,000,000USD | 762,000,000USD | 772,000,000USD |
| Current Deferred Revenue | — | 613,000,000USD | 621,000,000USD | 576,000,000USD | 557,000,000USD | 558,000,000USD | 572,000,000USD | 563,000,000USD |
| Net Debt | — | 4,519,000,000USD | 4,157,000,000USD | 3,495,000,000USD | 7,323,000,000USD | 7,379,000,000USD | 7,248,000,000USD | 7,337,000,000USD |
| Short Long Term Debt Total | — | 5,080,000,000USD | 5,035,000,000USD | 5,137,000,000USD | 7,815,000,000USD | 7,913,000,000USD | 8,010,000,000USD | 8,109,000,000USD |
| Property Plant Equipment Gross | — | 3,598,000,000USD | 3,193,000,000USD | 3,179,000,000USD | 3,044,000,000USD | 2,864,000,000USD | 3,610,000,000USD | 3,597,000,000USD |
| Common Stock Shares Outstanding | — | 175,500,000shares | 175,300,000shares | 175,400,000shares | 175,200,000shares | 174,800,000shares | 174,500,000shares | 173,900,000shares |
| Non Current Assets Total | — | 10,514,000,000USD | 10,435,000,000USD | 9,566,000,000USD | 11,866,000,000USD | 11,474,000,000USD | 11,208,000,000USD | 11,391,000,000USD |
| Non Current Liabilities Total | — | 5,782,000,000USD | 6,109,000,000USD | 6,049,000,000USD | 8,809,000,000USD | 8,699,000,000USD | 8,795,000,000USD | 8,649,000,000USD |
| Non Current Liabilities Other | — | 478,000,000USD | 546,000,000USD | 437,000,000USD | 371,000,000USD | 279,000,000USD | 410,000,000USD | 305,000,000USD |
| Non Currrent Assets Other | — | 848,000,000USD | 813,000,000USD | 747,000,000USD | 2,977,000,000USD | 2,917,000,000USD | 665,000,000USD | 549,000,000USD |
| Net Working Capital | — | 237,000,000USD | 723,000,000USD | 1,469,000,000USD | 588,000,000USD | 487,000,000USD | 546,000,000USD | 450,000,000USD |
| Unclassified Current Liabilities | — | -505,000,000USD | — | — | 117,000,000USD | 40,000,000USD | -78,000,000USD | -300,000,000USD |
| Unclassified Non Current Liabilities | — | 729,000,000USD | 528,000,000USD | 475,000,000USD | 623,000,000USD | 607,000,000USD | 575,000,000USD | 535,000,000USD |
| Unclassified Equity | — | 3,825,000,000USD | 3,873,000,000USD | 3,852,000,000USD | 3,804,000,000USD | 3,779,000,000USD | 3,769,000,000USD | 3,742,000,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Assets | 14,294,000,000USD | 14,457,000,000USD | 13,943,000,000USD | 13,594,000,000USD | 14,075,000,000USD | — |
| Intangible Assets | 2,592,000,000USD | 2,544,000,000USD | 2,902,000,000USD | 3,252,000,000USD | 3,661,000,000USD | — |
| Other Current Assets | 881,000,000USD | 293,000,000USD | 155,000,000USD | 126,000,000USD | 108,000,000USD | — |
| Total Liab | 9,245,000,000USD | 11,498,000,000USD | 2,277,000,000USD | 1,852,000,000USD | 2,016,000,000USD | — |
| Total Stockholder Equity | 5,049,000,000USD | 2,959,000,000USD | 11,666,000,000USD | 11,742,000,000USD | 12,059,000,000USD | — |
| Other Current Liab | 1,828,000,000USD | 1,191,000,000USD | 571,000,000USD | 377,000,000USD | 1,057,000,000USD | — |
| Common Stock | 2,000,000USD | 2,000,000USD | 2,000,000USD | 12,239,000,000USD | 12,259,000,000USD | — |
| Capital Stock | 2,000,000USD | 2,000,000USD | 2,000,000USD | — | — | — |
| Retained Earnings | 1,797,000,000USD | 242,000,000USD | 0USD | — | — | — |
| Good Will | 5,704,000,000USD | 6,377,000,000USD | 6,535,000,000USD | 6,434,000,000USD | 6,666,000,000USD | — |
| Cash | 878,000,000USD | 762,000,000USD | 194,000,000USD | 61,000,000USD | 91,000,000USD | — |
| Cash And Short Term Investments | 878,000,000USD | 762,000,000USD | 194,000,000USD | 61,000,000USD | 91,000,000USD | — |
| Total Current Assets | 3,859,000,000USD | 3,249,000,000USD | 2,519,000,000USD | 2,231,000,000USD | 2,189,000,000USD | — |
| Total Current Liabilities | 3,136,000,000USD | 2,703,000,000USD | 1,728,000,000USD | 1,311,000,000USD | 1,406,000,000USD | — |
| Current Deferred Revenue | 621,000,000USD | 572,000,000USD | 574,000,000USD | 559,000,000USD | 574,000,000USD | — |
| Net Debt | 4,157,000,000USD | 7,248,000,000USD | 8,109,000,000USD | 34,000,000USD | 21,000,000USD | — |
| Short Long Term Debt Total | 5,035,000,000USD | 8,010,000,000USD | 8,303,000,000USD | 95,000,000USD | 112,000,000USD | — |
| Long Term Debt | 5,035,000,000USD | 7,810,000,000USD | 8,303,000,000USD | — | — | — |
| Net Receivables | 1,034,000,000USD | 1,229,000,000USD | 1,313,000,000USD | 1,171,000,000USD | 1,177,000,000USD | — |
| Inventory | 1,066,000,000USD | 965,000,000USD | 857,000,000USD | 873,000,000USD | 813,000,000USD | — |
| Accounts Payable | 687,000,000USD | 618,000,000USD | 477,000,000USD | 348,000,000USD | 320,000,000USD | — |
| Property Plant Equipment Net | 1,326,000,000USD | 1,622,000,000USD | 1,457,000,000USD | 1,319,000,000USD | 1,306,000,000USD | — |
| Property Plant Equipment Gross | 3,193,000,000USD | 3,610,000,000USD | 3,338,000,000USD | 3,090,000,000USD | 2,980,000,000USD | — |
| Accumulated Other Comprehensive Income | -625,000,000USD | -1,056,000,000USD | -337,000,000USD | -497,000,000USD | -200,000,000USD | — |
| Common Stock Shares Outstanding | 175,300,000shares | 173,700,000shares | 172,709,505shares | 172,466,022shares | 172,466,022shares | 172,466,022shares |
| Non Current Assets Total | 10,435,000,000USD | 11,208,000,000USD | 11,424,000,000USD | 11,363,000,000USD | 11,886,000,000USD | — |
| Non Current Liabilities Total | 6,109,000,000USD | 8,795,000,000USD | 549,000,000USD | 541,000,000USD | 610,000,000USD | — |
| Non Current Liabilities Other | 546,000,000USD | 410,000,000USD | 224,000,000USD | 235,000,000USD | 245,000,000USD | — |
| Non Currrent Assets Other | 813,000,000USD | 665,000,000USD | 530,000,000USD | 358,000,000USD | 253,000,000USD | — |
| Net Working Capital | 723,000,000USD | 546,000,000USD | 1,145,000,000USD | 920,000,000USD | 783,000,000USD | — |
| Unclassified Non Current Liabilities | 528,000,000USD | 575,000,000USD | -7,978,000,000USD | 306,000,000USD | 365,000,000USD | — |
| Unclassified Equity | 3,873,000,000USD | 3,769,000,000USD | 11,999,000,000USD | — | — | — |
| Short Term Debt | — | 200,000,000USD | 29,000,000USD | 27,000,000USD | 29,000,000USD | — |
| Short Long Term Debt | — | 200,000,000USD | — | — | — | — |
| Unclassified Current Liabilities | — | -78,000,000USD | 77,000,000USD | — | -574,000,000USD | — |
| Short Term Investments | — | — | 406,000,000USD | — | — | — |
| Unclassified Current Assets | — | — | -406,000,000USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 268,000,000USD |
| Stock Based Compensation | 89,000,000USD |
| Deferred Income Tax | -88,000,000USD |
| Change To Account Receivables | -286,000,000USD |
| Change To Inventory | 18,000,000USD |
| Change To Liabilities | 26,000,000USD |
| Change In Working Capital | -242,000,000USD |
| Operating Cash Flow | 38,000,000USD |
| Capital Expenditures | -167,000,000USD |
| Other Investing Activities | -3,000,000USD |
| Unclassified Investing Cash Flow | 6,000,000USD |
| Investing Cash Flow | -164,000,000USD |
| Net Debt Issuance | 0USD |
| Net Common Stock Issuance | -355,000,000USD |
| Other Financing Activities | -44,000,000USD |
| Unclassified Financing Cash Flow | 49,000,000USD |
| Financing Cash Flow | -350,000,000USD |
| Effect Of Forex Changes On Cash | 1,000,000USD |
| Change In Cash | -475,000,000USD |
| End Cash Flow | 403,000,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 13,000,000USD | 63,000,000USD | 1,266,000,000USD | 90,000,000USD | 137,000,000USD | 31,000,000USD | 122,000,000USD | 89,000,000USD |
| Depreciation | 135,000,000USD | 117,000,000USD | 121,000,000USD | 122,000,000USD | 129,000,000USD | 150,000,000USD | 133,000,000USD | 133,000,000USD |
| Stock Based Compensation | 51,000,000USD | 37,000,000USD | 41,000,000USD | 34,000,000USD | 49,000,000USD | 25,000,000USD | 27,000,000USD | 56,000,000USD |
| Other Non Cash Items | 13,000,000USD | -43,000,000USD | -1,587,000,000USD | 17,000,000USD | 15,000,000USD | 4,000,000USD | 11,000,000USD | 10,000,000USD |
| Change To Account Receivables | -6,000,000USD | 5,000,000USD | 84,000,000USD | -22,000,000USD | 11,000,000USD | 62,000,000USD | 13,000,000USD | 123,000,000USD |
| Change To Inventory | -32,000,000USD | -5,000,000USD | -57,000,000USD | -45,000,000USD | -32,000,000USD | -33,000,000USD | -42,000,000USD | -5,000,000USD |
| Change In Working Capital | -360,000,000USD | -6,000,000USD | 105,000,000USD | -61,000,000USD | -157,000,000USD | 71,000,000USD | -87,000,000USD | 98,000,000USD |
| Total Cash From Operating Activities | -189,000,000USD | 95,000,000USD | 76,000,000USD | 169,000,000USD | 29,000,000USD | 219,000,000USD | 169,000,000USD | 355,000,000USD |
| Capital Expenditures | -84,000,000USD | -63,000,000USD | -97,000,000USD | -110,000,000USD | -109,000,000USD | -127,000,000USD | -93,000,000USD | -58,000,000USD |
| Free Cash Flow | -273,000,000USD | 32,000,000USD | -21,000,000USD | 59,000,000USD | -80,000,000USD | 92,000,000USD | 76,000,000USD | 297,000,000USD |
| Total Cashflows From Investing Activities | -77,000,000USD | -745,000,000USD | 3,766,000,000USD | -110,000,000USD | -114,000,000USD | -127,000,000USD | -93,000,000USD | -58,000,000USD |
| Net Borrowings | 46,000,000USD | -100,000,000USD | -2,770,000,000USD | -100,000,000USD | -100,000,000USD | -100,000,000USD | -200,000,000USD | — |
| Total Cash From Financing Activities | -50,000,000USD | -115,000,000USD | -2,693,000,000USD | -110,000,000USD | -139,000,000USD | -104,000,000USD | -202,000,000USD | -396,000,000USD |
| Sale Purchase Of Stock | -67,000,000USD | — | — | — | 0USD | — | — | — |
| Change In Cash | -317,000,000USD | -764,000,000USD | 1,150,000,000USD | -42,000,000USD | -228,000,000USD | -10,000,000USD | -125,000,000USD | -99,000,000USD |
| Begin Period Cash Flow | 878,000,000USD | 1,642,000,000USD | 492,000,000USD | 534,000,000USD | 762,000,000USD | 772,000,000USD | 897,000,000USD | 996,000,000USD |
| End Period Cash Flow | 561,000,000USD | 878,000,000USD | 1,642,000,000USD | 492,000,000USD | 534,000,000USD | 762,000,000USD | 772,000,000USD | 897,000,000USD |
| Other Cashflows From Investing Activities | 7,000,000USD | -6,000,000USD | 3,863,000,000USD | — | -5,000,000USD | — | — | — |
| Other Cashflows From Financing Activities | -29,000,000USD | -15,000,000USD | 77,000,000USD | -10,000,000USD | -39,000,000USD | -4,000,000USD | -2,000,000USD | -396,000,000USD |
| Unclassified Operating Cash Flow | -41,000,000USD | -73,000,000USD | 130,000,000USD | -33,000,000USD | -144,000,000USD | -62,000,000USD | -37,000,000USD | -31,000,000USD |
| Unclassified Investing Cash Flow | — | -676,000,000USD | -3,766,000,000USD | 110,000,000USD | 114,000,000USD | 127,000,000USD | 93,000,000USD | 58,000,000USD |
| Investments | — | — | 3,766,000,000USD | -110,000,000USD | -114,000,000USD | -127,000,000USD | -93,000,000USD | -58,000,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Net Income | 1,556,000,000USD | 479,000,000USD | 1,346,000,000USD | 1,343,000,000USD | 1,460,000,000USD | 1,138,000,000USD |
| Depreciation | 489,000,000USD | 555,000,000USD | 561,000,000USD | 578,000,000USD | 597,000,000USD | 599,000,000USD |
| Stock Based Compensation | 161,000,000USD | 112,000,000USD | 39,000,000USD | 37,000,000USD | 38,000,000USD | 35,000,000USD |
| Other Non Cash Items | -1,598,000,000USD | 34,000,000USD | -15,000,000USD | 64,000,000USD | 74,000,000USD | 74,000,000USD |
| Change To Account Receivables | 78,000,000USD | 276,000,000USD | -129,000,000USD | -32,000,000USD | -1,000,000USD | 41,000,000USD |
| Change To Inventory | -139,000,000USD | -132,000,000USD | 23,000,000USD | -82,000,000USD | -136,000,000USD | 43,000,000USD |
| Change In Working Capital | -119,000,000USD | 160,000,000USD | 126,000,000USD | -202,000,000USD | 67,000,000USD | 234,000,000USD |
| Total Cash From Operating Activities | 369,000,000USD | 1,185,000,000USD | 1,915,000,000USD | 1,679,000,000USD | 2,202,000,000USD | 2,026,000,000USD |
| Capital Expenditures | -379,000,000USD | -380,000,000USD | -290,000,000USD | -251,000,000USD | -277,000,000USD | -271,000,000USD |
| Free Cash Flow | -10,000,000USD | 805,000,000USD | 1,625,000,000USD | 1,428,000,000USD | 1,925,000,000USD | 1,755,000,000USD |
| Total Cashflows From Investing Activities | 2,797,000,000USD | -380,000,000USD | -230,000,000USD | -253,000,000USD | -278,000,000USD | 228,000,000USD |
| Net Borrowings | -3,070,000,000USD | 8,003,000,000USD | 0USD | 0USD | — | — |
| Total Cash From Financing Activities | -3,057,000,000USD | -240,000,000USD | -1,552,000,000USD | -1,460,000,000USD | -1,960,000,000USD | -2,211,000,000USD |
| Change In Cash | 116,000,000USD | 568,000,000USD | 133,000,000USD | -30,000,000USD | -33,000,000USD | 40,000,000USD |
| Begin Period Cash Flow | 762,000,000USD | 194,000,000USD | 61,000,000USD | 91,000,000USD | 124,000,000USD | 84,000,000USD |
| End Period Cash Flow | 878,000,000USD | 762,000,000USD | 194,000,000USD | 61,000,000USD | 91,000,000USD | 124,000,000USD |
| Other Cashflows From Investing Activities | 3,872,000,000USD | — | — | -2,000,000USD | -1,000,000USD | 30,000,000USD |
| Other Cashflows From Financing Activities | 13,000,000USD | -8,243,000,000USD | -1,552,000,000USD | -1,460,000,000USD | -1,960,000,000USD | -1,766,000,000USD |
| Unclassified Operating Cash Flow | -120,000,000USD | -155,000,000USD | -142,000,000USD | -141,000,000USD | -34,000,000USD | -54,000,000USD |
| Unclassified Investing Cash Flow | -696,000,000USD | 380,000,000USD | 290,000,000USD | 253,000,000USD | 278,000,000USD | 241,000,000USD |
| Investments | — | -380,000,000USD | -230,000,000USD | -253,000,000USD | -278,000,000USD | 228,000,000USD |
| Unclassified Financing Cash Flow | — | — | — | — | — | -445,000,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Product | Cost Of Software And Rentals | 511,000,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Product | 1,698,000,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Segment | Dental Solutions | 396,000,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Segment | Health Information Systems | 354,000,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Segment | Med Surg | 1,372,000,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Segment | Purification And Filtration | 0 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Product | Cost Of Software And Rentals | 493,000,000 | USD | 0001964738-26-000024 |
| Q1 2026Quarterly · 2026-03-31 | Product | Product | 1,513,000,000 | USD | 0001964738-26-000024 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Dental Solutions | 354,000,000 | USD | 0001964738-26-000024 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Health Information Systems | 342,000,000 | USD | 0001964738-26-000024 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Med Surg | 1,234,000,000 | USD | 0001964738-26-000024 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Purification And Filtration | 0 | USD | 0001964738-26-000024 |
| Q4 2025Quarterly · 2025-12-31 | Product | Cost Of Software And Rentals | 508,000,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Product | 1,490,000,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Dental Solutions | 343,000,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Health Information Systems | 347,000,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Med Surg | 1,236,000,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Other | 135,000,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Purification And Filtration | 0 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Geography | International | 3,657,000,000 | USD | 0001964738-26-000007 |
| FY 2025Yearly · 2025-12-31 | Geography | United States | 4,668,000,000 | USD | 0001964738-26-000007 |
| FY 2025Yearly · 2025-12-31 | Product | Cost Of Software And Rentals | 1,976,000,000 | USD | 0001964738-26-000007 |
| FY 2025Yearly · 2025-12-31 | Product | Product | 6,349,000,000 | USD | 0001964738-26-000007 |
| FY 2025Yearly · 2025-12-31 | Segment | Dental Solutions | 1,349,000,000 | USD | 0001964738-26-000007 |
| FY 2025Yearly · 2025-12-31 | Segment | Health Information Systems | 1,360,000,000 | USD | 0001964738-26-000007 |
| FY 2025Yearly · 2025-12-31 | Segment | Med Surg | 4,817,000,000 | USD | 0001964738-26-000007 |
| FY 2025Yearly · 2025-12-31 | Segment | Other | 302,000,000 | USD | 0001964738-26-000007 |
| FY 2025Yearly · 2025-12-31 | Segment | Purification And Filtration | 497,000,000 | USD | 0001964738-26-000007 |
| Q3 2025Quarterly · 2025-09-30 | Product | Cost Of Software And Rentals | 502,000,000 | USD | 0001964738-25-000091 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product | 1,594,000,000 | USD | 0001964738-25-000091 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Dental Solutions | 340,000,000 | USD | 0001964738-25-000091 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Health Information Systems | 345,000,000 | USD | 0001964738-25-000091 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Med Surg | 1,206,000,000 | USD | 0001964738-25-000091 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Other | 77,000,000 | USD | 0001964738-25-000091 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Purification And Filtration | 128,000,000 | USD | 0001964738-25-000091 |
| Q2 2025Quarterly · 2025-06-30 | Product | Cost Of Software And Rentals | 493,000,000 | USD | 0001964738-25-000064 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product | 1,668,000,000 | USD | 0001964738-25-000064 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Dental Solutions | 338,000,000 | USD | 0001964738-25-000064 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Health Information Systems | 339,000,000 | USD | 0001964738-25-000064 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Med Surg | 1,218,000,000 | USD | 0001964738-25-000064 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Other | 14,000,000 | USD | 0001964738-25-000064 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Purification And Filtration | 252,000,000 | USD | 0001964738-25-000064 |
| Q1 2025Quarterly · 2025-03-31 | Product | Cost Of Software And Rentals | 473,000,000 | USD | 0001964738-26-000024 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product | 1,597,000,000 | USD | 0001964738-26-000024 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Dental Solutions | 328,000,000 | USD | 0001964738-26-000024 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Health Information Systems | 329,000,000 | USD | 0001964738-26-000024 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Med Surg | 1,157,000,000 | USD | 0001964738-26-000024 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Other | 76,000,000 | USD | 0001964738-26-000024 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Purification And Filtration | 180,000,000 | USD | 0001964738-26-000024 |
| Q4 2024Quarterly · 2024-12-31 | Product | Cost Of Software And Rentals | 493,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Product | 1,582,000,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Geography | International | 3,695,000,000 | USD | 0001964738-26-000007 |
| FY 2024Yearly · 2024-12-31 | Geography | United States | 4,559,000,000 | USD | 0001964738-26-000007 |
| FY 2024Yearly · 2024-12-31 | Product | Cost Of Software And Rentals | 1,906,000,000 | USD | 0001964738-26-000007 |
| FY 2024Yearly · 2024-12-31 | Product | Product | 6,348,000,000 | USD | 0001964738-26-000007 |
| FY 2024Yearly · 2024-12-31 | Segment | Dental Solutions | 1,295,000,000 | USD | 0001964738-26-000007 |
| FY 2024Yearly · 2024-12-31 | Segment | Health Information Systems | 1,306,000,000 | USD | 0001964738-26-000007 |
| FY 2024Yearly · 2024-12-31 | Segment | Med Surg | 4,637,000,000 | USD | 0001964738-26-000007 |
| FY 2024Yearly · 2024-12-31 | Segment | Other | 307,000,000 | USD | 0001964738-26-000007 |
| FY 2024Yearly · 2024-12-31 | Segment | Purification And Filtration | 709,000,000 | USD | 0001964738-26-000007 |
| Q3 2024Quarterly · 2024-09-30 | Product | Cost Of Software And Rentals | 474,000,000 | USD | 0001964738-25-000091 |
| Q3 2024Quarterly · 2024-09-30 | Product | Product | 1,608,000,000 | USD | 0001964738-25-000091 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Dental Solutions | 313,000,000 | USD | 0001964738-25-000091 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Health Information Systems | 326,000,000 | USD | 0001964738-25-000091 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Med Surg | 1,182,000,000 | USD | 0001964738-25-000091 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Other | 81,000,000 | USD | 0001964738-25-000091 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Purification And Filtration | 180,000,000 | USD | 0001964738-25-000091 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Dental Solutions | 331,000,000 | USD | 0001964738-25-000064 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Health Information Systems | 328,000,000 | USD | 0001964738-25-000064 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Med Surg | 1,162,000,000 | USD | 0001964738-25-000064 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Other | 22,000,000 | USD | 0001964738-25-000064 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Purification And Filtration | 238,000,000 | USD | 0001964738-25-000064 |
| FY 2023Yearly · 2023-12-31 | Geography | International | 3,726,000,000 | USD | 0001964738-26-000007 |
| FY 2023Yearly · 2023-12-31 | Geography | United States | 4,471,000,000 | USD | 0001964738-26-000007 |
| FY 2023Yearly · 2023-12-31 | Product | Cost Of Software And Rentals | 1,901,000,000 | USD | 0001964738-26-000007 |
| FY 2023Yearly · 2023-12-31 | Product | Product | 6,296,000,000 | USD | 0001964738-26-000007 |
| FY 2023Yearly · 2023-12-31 | Segment | Dental Solutions | 1,329,000,000 | USD | 0001964738-26-000007 |
| FY 2023Yearly · 2023-12-31 | Segment | Health Information Systems | 1,285,000,000 | USD | 0001964738-26-000007 |
| FY 2023Yearly · 2023-12-31 | Segment | Med Surg | 4,632,000,000 | USD | 0001964738-26-000007 |
| FY 2023Yearly · 2023-12-31 | Segment | Other | 262,000,000 | USD | 0001964738-26-000007 |
| FY 2023Yearly · 2023-12-31 | Segment | Purification And Filtration | 689,000,000 | USD | 0001964738-26-000007 |
| FY 2022Yearly · 2022-12-31 | Geography | International | 3,680,000,000 | USD | 0001964738-25-000019 |
| FY 2022Yearly · 2022-12-31 | Geography | United States | 4,450,000,000 | USD | 0001964738-25-000019 |
| FY 2022Yearly · 2022-12-31 | Product | Cost Of Software And Rentals | 1,830,000,000 | USD | 0001964738-25-000019 |
| FY 2022Yearly · 2022-12-31 | Product | Product | 6,300,000,000 | USD | 0001964738-25-000019 |
| FY 2022Yearly · 2022-12-31 | Segment | Dental Solutions | 1,327,000,000 | USD | 0001964738-25-000019 |
| FY 2022Yearly · 2022-12-31 | Segment | Health Information Systems | 1,227,000,000 | USD | 0001964738-25-000019 |
| FY 2022Yearly · 2022-12-31 | Segment | Med Surg | 4,585,000,000 | USD | 0001964738-25-000019 |
| FY 2022Yearly · 2022-12-31 | Segment | Purification And Filtration | 991,000,000 | USD | 0001964738-25-000019 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.